**iuvo BioScience** is a biotechnology startup founded in 2015, positioning itself as a contract research organization catering to the pharmaceutical and medical device industries. With a robust service portfolio spanning laboratory services, clinical research, and consulting, iuvo BioScience offers support throughout the entire product development life cycle, emphasizing safety, biocompatibility, and regulatory compliance, including ISO 10993:2018 testing. The company's clinical research arm specializes in ophthalmology-related services. Additionally, **iuvo BioScience** operates an AAALAC-accredited vivarium, providing GLP-compliant toxicology testing, microbiology, and analytical chemistry testing services. Notably, the company is certified to ISO 13485:2016 and accredited to ISO 17025:2017 quality system standards, ensuring adherence to high industry standards. **iuvo BioScience** prides itself on its technical consulting services, encompassing areas such as regulatory affairs, preclinical research, CMC, and quality systems. Its client-centric approach aims to accommodate specific testing requirements, full program management, and comprehensive research inquiries, consolidating its position as a reliable Partner Research Organization. Despite the lack of specific information on the headquarters and recent investment, **iuvo BioScience** is well-poised within the biotechnology and medical devices sectors, leveraging decades of industry experience to deliver exceptional scientific support to healthcare and medtech companies globally.
There is no investment information
No recent news or press coverage available for iuvo BioScience.